You Searched For "cipla remdesivir" and got 20 results
Sort By:
3 mins read
India is getting healthier and that’s affecting the health of pharma companies
Same time last year in the thick of the second wave, millions of Covid-infected Indians were gulpin…
3 mins read
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
2 mins read
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…
4 mins read
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
1 min read
Cipla launches generic remdesivir for COVID-19 patients
Commenting on the launch, Cipla Ltd MD and Global CEO Umang Vohra said, "Cipla appreciates the stro…
PTI
2 mins read
Cipla says COVID-19 drug Remdesivir will hit market this week
As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…
2 mins read
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
1 min read
Fabiflu, Covifor, Cipremi and other drugs approved or under trial for COVID-19 patients in India
There is some good news for Indians — medicines showing promising results to treat coronavirus. Ind…
Preeti Soni
2 mins read
COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir
This comes a day after the Drug Controller General of India (DCGI), considering the emergency and u…
PTI
1 min read
Cipla inks licensing pact with Gilead Sciences for potential COVID-19 treatment drug remdesivir
The EUA is based on available data from two global clinical trials – US National Institute for All…
PTI
1 min read
Cipla shares gain over 3 pc as co launches generic remdesivir for COVID-19 patients
Remdesivir is the only USFDA-approved EUA for treatment for adult and paediatric patients hospitali…
PTI
1 min read
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial
Cipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for rest…
PTI
5 mins read
The utter chaos and confusion over Remdesivir in India is making the COVID-19 second wave worse
Remdesivir is not a proven treatment against COVID-19. Governments have said it, the courts hav…
6 mins read
Inside the treacherous black market for Remdesivir in India— from private hospitals to distributors
The black market for drugs that could treat COVID-19 is surging in India, especially when it comes …
3 mins read
Thanks to Remdesivir, Kwality Pharma’s stock is up from ₹59 to over ₹922 in just over nine months
Stocks of drug makers have been on a tear but none more than the Punjab-based Kwality Pharmaceutica…
2 mins read
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
5 mins read
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
4 mins read
Favipiravir shortage may get filled up in a couple of weeks provided people don't hoard
Like Sheth, Varun Mimani, the Head of Supply Chain at 1mg said that the severity and natur…
3 mins read
Top stock movers — Tata Motors, SBI Cards, Cochin Shipyard, Zydus Cadila, Cipla, Dr Reddy’s, MphasiS, and others
Indian stock market indices opened on a higher note on Friday, tracking gains in index majors HDFC …
2 mins read
Top stocks to watch — Cipla, Zydus Cadila, Dr Reddy Laboratories, Tech Mahindra, Avenue Supermarts, Cochin Shipyard, and others
Amidst mixed cues from the global markets, the Indian equities are likely to open flat on Friday. T…